However, a study by Bai et al. showed that after blocking PD-1 and TIM-3, CD8 + T-cell functions improved, thereby increasing disease-free survival in pancreatic cancer patients after tumor resection. The gene discussed is HAVCR2; the disease is familial pancreatic carcinoma.